Sitagliptin malate

Sitagliptin malate is used to treat type 2 diabetes mellitus. It functions as a DPP-4 (dipeptidyl peptidase-4) inhibitor, similar to sitagliptin hydrochloride, and helps improve blood sugar control by increasing incretin levels. These incretins boost insulin secretion and reduce glucagon release in response to meals, leading to better glucose regulation. The malate salt form is used to enhance the drug’s stability or solubility but does not change its therapeutic effect. Sitagliptin malate is often used alone or with other antidiabetic drugs like metformin. It is grouped under the following drug class(es): DPP-4 inhibitors and Hypoglycemics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Sitagliptin L-malate and UNII-6Q9M3E3GG7. Its PubChem CID is 163203575.

CAS No 1240039-02-4
Molecular Formula C20H21F6N5O6
Molecular Weight 541.4 g/mol
Synonyms (3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one;(2S)-2-hydroxybutanedioic acid

Frequently Asked Questions